Johnny M. Shaw


Johnny Shaw is a part of the litigation teams representing businesses and consumers in complex litigation concerning alleged pharmaceutical pay-for-delay schemes, price-fixing, monopolization, and other violations of federal and state antitrust laws.

Johnny first joined Motley Rice in 2016 as a paralegal and law clerk, supporting trial teams for In re Solodyn Antitrust Litigation ($43 million settlement in 2018*) and In re Loestrin Antitrust Litigation ($63.5 million settlement in 2020*) before completing his Juris Doctor. 

Currently, Johnny litigates end-payor plaintiff claims alleging delayed generic drug market entry in In re Zetia Antitrust Litigation, and In re Xyrem Antitrust Litigation. He also represents plaintiffs alleging monopolization claims in In re Keurig Antitrust Litigation regarding single-serve coffee pods, and Caccuri v. Sony Interactive Entertainment regarding the sale of digitally distributed video games for PlayStation gaming consoles.
Johnny was a member of the Fordham Law Review and published a student note titled Avoiding Market Definition Under Section 1 of the Sherman Act, 88 Fordham L. Rev. 1133 (2019). He was awarded the Order of the Coif, worked as a research assistant in the area of constitutional rights at Fordham University and has additional experience as a legal intern for Rhode Island Legal Services.

*Please remember that every case is different. Any result we achieve for one client in one matter does not necessarily indicate similar results can be obtained for other clients.


J.D., magna cum laude, Fordham University School of Law, 2021

B.A., McGill University, 2010

Licensed In

  • New York

Admitted to Practice Before

Southern District of New York


New York State Bar Association